Delivery Order SPE2DB20D1100-SPE2DB25FB3H1

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,600.99 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a generic prescription medication. The award has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,965.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through May 2, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide ENTECAVIR 0.5 MG TABLET 30S. The $1,137 Firm Fixed Price Delivery Order contract has a completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $30,886.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ENTECAVIR 0.5 MG TABLET 30S, a medication, with a completion date of December 20, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,203.97 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,704.03 firm fixed-price delivery order is for the supply of 4567538526 - ENTECAVIR 0.5 MG TABLET 30S. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order with a firm fixed price valued at $2,244.95, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTECAVIR 0.5 MG TABLET 30S, with a completion date of August 6, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,019.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENTECAVIR 0.5 MG TABLET 30S. The $5,407.01 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,610.13 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB3H1
    Delivery Order

This federal contract award, valued at $2,099.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 26, 2025. This award is a Delivery Order contract with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/24/25, 10:00 AM